Amyris announces $50M common stock offering and private placement

Like
1
Favorite

Amyris announces $50M common stock offering and private placement

seekingalpha2022-12-29

Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct offering of common stock and a private placement to raise ~$50M in gross proceeds. The registered ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

wyyw
·2022-12-30
How does this affect the stock price? Will it be more stable?
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2295439229?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1126636461/image_1126636461.jpg","is_english":true,"pubTime":"2022-12-29 21:20","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2295439229","market":"us","top_or_hot":-1,"title":"Amyris announces $50M common stock offering and private placement","media":"seekingalpha","content":"<div>\n<p>Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct offering of common stock and a private placement to raise ~$50M in gross proceeds. The registered ...</p>\n\n<a href=\"https://seekingalpha.com/news/3921118-amrs-stock-dips-50m-common-stock-offering-private-placement\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amyris announces $50M common stock offering and private placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmyris announces $50M common stock offering and private placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-12-29 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3921118-amrs-stock-dips-50m-common-stock-offering-private-placement><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct offering of common stock and a private placement to raise ~$50M in gross proceeds. The registered ...</p>\n\n<a href=\"https://seekingalpha.com/news/3921118-amrs-stock-dips-50m-common-stock-offering-private-placement\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMRS","symbol_name":"阿米瑞斯","start_time":0,"source_url":"https://seekingalpha.com/news/3921118-amrs-stock-dips-50m-common-stock-offering-private-placement","article_id":"2295439229","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1126636461/image_1126636461.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2295439229","pubTimestamp":1672320031,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct of","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"AMRS":"阿米瑞斯","BK4109":"特种化学制品"},"translate_title":"Amyris宣布发行5000万美元普通股和私募","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMRS":1},"content_text":"Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct offering of common stock and a private placement to raise ~$50M in gross proceeds. The registered direct offering allows the purchase and sale of 20M shares of the company's common stock and warrants to purchase up to 15M total shares of common stock. Each share of common stock will be available with a warrant at a combined purchase price of $1.50, Amyris (AMRS) said, adding that warrants will be immediately exercisable at $1.80 per share of common stock over five years. Meanwhile, the agreement for private placement with Foris Ventures, LLC allows the purchase and sale of 13.3M shares of common stock and warrants to purchase up to 10M shares of common stock in total. Foris Ventures is a company linked to Amyris (AMRS) board member John Doerr. The direct offering and private placement are expected to close on or about Dec. 30. The company expects the transactions to generate about $50M in gross proceeds, which it has earmarked for general corporate purposes after deducting the placement agent's fees and other expenses. Seeking Alpha contributor Henrik Alex wrote yesterday that Amyris (AMRS) is \"likely to run out of funds within weeks.\"","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9927108608,"gmtCreate":1672412414405,"gmtModify":1676538687732,"author":{"id":"3580726036584621","authorId":"3580726036584621","authorIdStr":"3580726036584621","name":"wyyw","avatar":"https://static.tigerbbs.com/2ccef0c08c538bfeaef3eb7c5e169006","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580726036584621"},"htmlText":"How does this affect the stock price? Will it be more stable?","listText":"How does this affect the stock price? Will it be more stable?","text":"How does this affect the stock price? Will it be more stable?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9927108608","repostId":2295439229,"repostType":2,"repost":{"id":"2295439229","pubTimestamp":1672320031,"share":"https://ttm.financial/m/news/2295439229?lang=&edition=fundamental","pubTime":"2022-12-29 21:20","market":"us","language":"en","title":"Amyris announces $50M common stock offering and private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2295439229","media":"seekingalpha","summary":"Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct of","content":"<html><body> <p>Synthetic biotechnology company Amyris, Inc. (<span>NASDAQ:AMRS</span>) announced Thursday a registered direct offering of common stock and a private placement to raise ~$50M in gross proceeds.</p> <p>The registered direct offering allows the purchase and sale of 20M shares<span> of the company's common stock and warrants to purchase up to 15M total shares of common stock.</span></p> <p>Each share of common stock will be available with a warrant at a combined purchase price of $1.50, Amyris (AMRS) said, adding that warrants will be immediately exercisable at $1.80 per share of common stock over five years.</p> <p>Meanwhile, the agreement for private placement with Foris Ventures, LLC allows the purchase and sale of 13.3M shares of common stock and warrants to purchase up to 10M shares of common stock in total. Foris Ventures is a company linked to Amyris (AMRS) board member John Doerr.</p> <p>The direct offering and private placement are expected to close on or about Dec. 30. The company expects the transactions to generate about $50M in gross proceeds, which it has earmarked for general corporate purposes after deducting the placement agent's fees and other expenses.</p> <p>Seeking Alpha contributor Henrik Alex wrote yesterday that Amyris (AMRS) is \"likely to run out of funds within weeks.\"</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amyris announces $50M common stock offering and private placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmyris announces $50M common stock offering and private placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-12-29 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3921118-amrs-stock-dips-50m-common-stock-offering-private-placement><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct offering of common stock and a private placement to raise ~$50M in gross proceeds. The registered ...</p>\n\n<a href=\"https://seekingalpha.com/news/3921118-amrs-stock-dips-50m-common-stock-offering-private-placement\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1126636461/image_1126636461.jpg","relate_stocks":{"AMRS":"阿米瑞斯","BK4109":"特种化学制品"},"source_url":"https://seekingalpha.com/news/3921118-amrs-stock-dips-50m-common-stock-offering-private-placement","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2295439229","content_text":"Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct offering of common stock and a private placement to raise ~$50M in gross proceeds. The registered direct offering allows the purchase and sale of 20M shares of the company's common stock and warrants to purchase up to 15M total shares of common stock. Each share of common stock will be available with a warrant at a combined purchase price of $1.50, Amyris (AMRS) said, adding that warrants will be immediately exercisable at $1.80 per share of common stock over five years. Meanwhile, the agreement for private placement with Foris Ventures, LLC allows the purchase and sale of 13.3M shares of common stock and warrants to purchase up to 10M shares of common stock in total. Foris Ventures is a company linked to Amyris (AMRS) board member John Doerr. The direct offering and private placement are expected to close on or about Dec. 30. The company expects the transactions to generate about $50M in gross proceeds, which it has earmarked for general corporate purposes after deducting the placement agent's fees and other expenses. Seeking Alpha contributor Henrik Alex wrote yesterday that Amyris (AMRS) is \"likely to run out of funds within weeks.\"","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}